After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Royalty Pharma plc is $12.70B. A total of 1.86 million shares were traded on the day, compared to an average of 2.74M shares.
In the most recent transaction, RIGGS RORY B sold 35,702 shares of RPRX for 27.55 per share on Jan 04 ’24. After the transaction, the Director now owns 20,099 company shares. In a previous transaction on Jan 03 ’24, RIGGS RORY B sold 199,098 shares at 27.79 per share. RPRX shares that Director owns now total 55,801.
Among the insiders who sold shares, RIGGS RORY B disposed of 235,200 shares on Jan 02 ’24 at a per-share price of $28.52. This resulted in the Director holding 254,899 shares of RPRX after the transaction. In another insider transaction, Avara Management Ltd sold 65,803 shares at $28.04 per share on Dec 29 ’23. Company shares held by the 10% Owner now total 2,477,520.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Royalty Pharma plc pays an annual dividend of $0.82, resulting in a dividend yield of 2.92%, and it has a price to earnings (P/E) ratio of 15.77. RPRX’s most recent ex-dividend date was 5/16/2024 when it declared a $0.21 quarterly dividend that was paid in cash on 6/14/2024. Previously, the company paid the dividend on 3/15/2024 with an ex-dividend date of 2/15/2024. The RPRX stock dividend was $0.21 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RPRX has a high of $31.66 and a low of $25.20.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RPRX’s latest balance sheet shows that the firm has $2.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.10B in debt and $171.25M in liabilities at the time. Its Book Value Per Share was $14.41, while its Total Shareholder’s Equity was $10.25B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPRX is Buy with a score of 4.43.
